Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Open Access
- 1 October 2009
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 284 (43), 29817-29827
- https://doi.org/10.1074/jbc.m109.050187
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ AssayOnline Journal of Public Health Informatics, 2009
- Lipid activation of protein kinasesJournal of Lipid Research, 2009
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentProceedings of the National Academy of Sciences of the United States of America, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Identification of GPR55 as a lysophosphatidylinositol receptorBiochemical and Biophysical Research Communications, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007
- Receptor regulation: β-arrestin moves up a notchNature, 2005
- A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor ActivationPublished by Elsevier BV ,1997
- Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine PhosphatasesPublished by Elsevier BV ,1996
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973